Detalhe da pesquisa
1.
Allogeneic natural killer cell therapy.
Blood
; 141(8): 856-868, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416736
2.
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Br J Haematol
; 202(2): 248-255, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129856
3.
The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation.
Am J Transplant
; 20(2): 589-592, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446673
4.
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Blood
; 137(13): 1832-1835, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156925
5.
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.
Blood Adv
; 8(4): 1042-1050, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051550
6.
Memory-like differentiation enhances NK cell responses against colorectal cancer.
Oncoimmunology
; 13(1): 2348254, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38737793
7.
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
J Clin Oncol
; 41(14): 2594-2606, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753699
8.
T-BET and EOMES sustain mature human NK cell identity and antitumor function.
J Clin Invest
; 133(13)2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279078
9.
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.
Clin Cancer Res
; 29(20): 4196-4208, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556118
10.
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport.
J Biol Chem
; 286(35): 30823-30836, 2011 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21730057
11.
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Clin Lymphoma Myeloma Leuk
; 22(10): 753-759, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780055
12.
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.
Sci Transl Med
; 14(633): eabm1375, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196021
13.
Mechanism for alternating access in neurotransmitter transporters.
Proc Natl Acad Sci U S A
; 105(30): 10338-43, 2008 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18647834
14.
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.
JCI Insight
; 6(16)2021 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423790
15.
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series.
JCO Precis Oncol
; 2: 1-10, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135131
16.
Genomic Landscape of Appendiceal Neoplasms.
JCO Precis Oncol
; 22018.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913983
17.
Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter.
J Biol Chem
; 282(40): 29441-7, 2007 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698848